Citigroup Inc Kura Oncology, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Citigroup Inc holds 65,010 shares of KURA stock, worth $505,777. This represents 0.0% of its overall portfolio holdings.

Number of Shares

65,010

Previous 33,333 95.03%

Holding current value

$505,777

Previous $686,000 85.13%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$18.57 - $23.23 $588,241 - $735,856	31,677 Added 95.03%	65,010 $1.27 Million
Q2 2024 Aug 12, 2024	SELL	$17.53 - $22.98 $4.18 Million - $5.48 Million	-238,563 Reduced 87.74%	33,333 $686,000
Q1 2024 May 10, 2024	BUY	$13.42 - $23.53 $2.73 Million - $4.79 Million	203,663 Added 298.48%	271,896 $5.8 Million
Q4 2023 Feb 09, 2024	SELL	$7.58 - $14.38 $229,855 - $436,059	-30,324 Reduced 30.77%	68,233 $981,000
Q3 2023 Nov 09, 2023	BUY	$8.44 - $11.86 $188,693 - $265,154	22,357 Added 29.34%	98,557 $898,000
Q2 2023 Aug 10, 2023	SELL	$9.62 - $13.99 $1.39 Million - $2.03 Million	-144,788 Reduced 65.52%	76,200 $806,000
Q1 2023 May 11, 2023	BUY	$10.71 - $14.6 $818,211 - $1.12 Million	76,397 Added 52.84%	220,988 $2.7 Million
Q4 2022 Feb 09, 2023	SELL	$11.23 - $16.9 $1.27 Million - $1.91 Million	-112,867 Reduced 43.84%	144,591 $1.79 Million
Q3 2022 Nov 10, 2022	BUY	$12.01 - $19.45 $1.91 Million - $3.09 Million	158,822 Added 161.02%	257,458 $3.52 Million
Q2 2022 Aug 10, 2022	BUY	$10.71 - $18.33 $707,202 - $1.21 Million	66,032 Added 202.53%	98,636 $1.81 Million
Q1 2022 May 12, 2022	SELL	$11.78 - $16.98 $1.66 Million - $2.4 Million	-141,330 Reduced 81.25%	32,604 $525,000
Q4 2021 Feb 10, 2022	BUY	$12.22 - $19.57 $251,133 - $402,183	20,551 Added 13.4%	173,934 $2.44 Million
Q3 2021 Nov 10, 2021	BUY	$15.42 - $21.72 $2.37 Million - $3.33 Million	153,383 New	153,383 $2.87 Million

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $520M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account